SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

Thyrocare Technologies

BSE: 539871 29 Jun 2025
Healthcare
₹ 989.45
Thyrocare Technologies Limited specializes in Healthcare Service Provider within the Healthcare sector.

Thyrocare Technologies - Share Price & Details

Market Cap
₹5,352
High /Low
1,073 / 605.0
Stock P/E
59.0
Book Value
₹103.0
Dividend Yield
1.78
ROCE
26.0
ROE
₹16.9
Face Value
10.0
PEG Ratio
218.0
EVEBITDA
₹26.1
Debt
24.7
CMP / FCF
47.1
Debt to equity
₹0.05
NP Ann
90.8
High price all time
1,466
Piotroski score
₹8.0
Graham Number
200.0
No. Eq. Shares
5.3
Net CF
₹8.38
Net profit
90.8
Price to book value
9.79
Interest Coverage
₹48.7
Low price all time
407.0
Industry PE
49.9
Reserves
₹494
Free Cash Flow
₹146

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
Thyrocare Technologies Limited1784.1219.51738.74.075,35259.0
SUVEN LIFE SCIENCES LTD.26.58-150.714.67-0.695147
YATHARTH HOSPITAL & TRAUMA CARNANANANA495437.9

Peer Comparison Chart


About Thyrocare Technologies

Thyrocare Technologies Limited, with Security Code 539871, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Thyrocare's Velumani urges recruiters to hire poor and humble employees 'for long term success'

(11 Jun 2025)
Drawing from experience, Thyrocare CEO A Velumani suggests hiring humble individuals for business success, a sentiment shared by Zoho's...
Read more →

Thyrocare Opens State-of-the-Art Lab in Srinagar, Kashmir in Association with Modern Diagnostic Center

(06 Jun 2025)
33rd lab in Thyrocare's expanding network to bring advanced, affordable diagnostic services across the Kashmir Valley.
Read more →

Thyrocare Technologies Achieves 52-Week High Amid Strong Financial Performance

(29 May 2025)
Thyrocare Technologies has achieved a new 52-week high, driven by strong financial performance, including a 67% growth in operating profit and a 20.45%...
Read more →

Thyrocare Technologies Demonstrates Strong Resilience and Outperformance in Challenging Market

(10 May 2025)
Thyrocare Technologies demonstrated strong performance on May 9, 2025, rebounding from an initial dip to reach an intraday high. The stock has consistently...
Read more →

InCred adds Thyrocare to conviction list, exits Marico, Pidilite, SBI Cards

(06 May 2025)
InCred Equities added Thyrocare Technologies to its conviction list while exiting Pidilite, Marico, and SBI Cards, citing shifting...
Read more →

Thyrocare Technologies Shows Improved Market Sentiment Amid Strong Financial Performance

(06 May 2025)
Thyrocare Technologies has recently experienced an evaluation adjustment reflecting a shift in its technical outlook.
Read more →